Insights

Research from the work.

Independent analysis on oncology reimbursement, evidence and health economics — written from the data behind our tools.

01
Oncology ValueJuly 2026 · 9 min read

The Marginal-Benefit Map of Modern Oncology

An appraisal of statistically significant but clinically marginal survival gains, using an independently developed evidence and toxicity dataset

→
02
Health PolicyJuly 2026 · 28 min read

Prescribed Minimum Benefit Status: Advanced Solid-Organ Malignancy

An appraisal of the >10% five-year survival test using an independently developed evidence and regimen-pricing dataset

→